Jefferies Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.62M Buy
+14,000
New +$2.95M 0.02% 516
2022
Q2
Sell
-1,270
Closed -$239K 1801
2022
Q1
$239K Sell
1,270
-300
-19% -$57K ﹤0.01% 1230
2021
Q4
$416K Buy
+1,570
New +$423K ﹤0.01% 1224
2019
Q1
Sell
-25,274
Closed -$1.33M 2571
2018
Q4
$1.33M Buy
+25,274
New +$1.48M 0.01% 1022
2018
Q3
Sell
-18,329
Closed -$862K 2693
2018
Q2
$862K Buy
18,329
+9,547
+109% +$393K ﹤0.01% 1346
2018
Q1
$318K Buy
+8,782
New +$309K ﹤0.01% 1771
2017
Q3
Sell
-8,001
Closed -$332K 2571
2017
Q2
$332K Sell
8,001
-2,439
-23% -$92.7K ﹤0.01% 1817
2017
Q1
$367K Buy
+10,440
New +$331K ﹤0.01% 1742
2013
Q4
Sell
-60
Closed -$1K 2172
2013
Q3
$1K Sell
60
-1,721
-97% -$17.1K ﹤0.01% 1882
2013
Q2
$15K Buy
+1,781
New +$15K ﹤0.01% 1746

Other funds holding RGEN

Jefferies Group's RGEN Position: Q3 2022 in Review

Jefferies Group opened a new position in Repligen (RGEN) in Q3 2022: 14,000 shares worth $2.62M. The stake represents 0.02% of the portfolio and ranks #516 among its holdings. This is a return to the name: Jefferies Group previously reported a position in RGEN as recently as Q1 2022.

Jefferies Group first reported a position in RGEN in Q2 2013 and has held it in 10 quarters since. 433 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • Jefferies Group held 14,000 shares of Repligen worth $2.62M as of Q3 2022.
  • Repligen was a new Jefferies Group position in Q3 2022.
  • Repligen made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #516 holding.
  • Jefferies Group first reported a position in Repligen in Q2 2013 and has held it in 10 quarters since.
  • 433 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.